Miriam Z Mintzer1, Roland R Griffiths. 1. Department of Psychiatry and Behavioral Sciences, Behavioral Biology Research Center, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. mmintzer@jhmi.edu
Abstract
RATIONALE: In addition to producing robust memory impairment, benzodiazepines also induce marked sedation. Thus, it is possible that the observed amnestic effects are secondary to more global sedative effects and do not reflect a specific primary benzodiazepine effect on memory mechanisms. OBJECTIVE: The objective was to use the nonspecific stimulant d-amphetamine to dissociate the sedative and memory-impairing effects of the benzodiazepine triazolam. MATERIALS AND METHODS: Single oral doses of placebo, triazolam alone (0.25, 0.50 mg/70 kg), d-amphetamine sulfate alone (20, 30 mg/70 kg), and triazolam (0.25, 0.50 mg/70 kg) and d-amphetamine sulfate (20, 30 mg/70 kg) conjointly (at all dose combinations) were administered to 18 healthy adult participants across nine sessions in a double-blind, staggered-dosing, crossover design. In addition to standard data analyses, analyses were also conducted on z-score standardized data, enabling effects to be directly compared across measures. RESULTS: Relative to the sedative measures, the memory measures generally exhibited a pattern of less reversal of triazolam's effects by d-amphetamine. The memory measures ranged in degree of reversal such that the most reversal was observed for reaction time on the n-back working memory task, and the least reversal was observed for accuracy on the Sternberg working memory task, with most measures showing an overall pattern of partial reversal. CONCLUSIONS: Benzodiazepines have specific effects on memory that are not merely a by-product of the drugs' sedative effects, and the degree to which sedative effects contribute to the amnestic effects varies as a function of the particular memory process being assessed.
RATIONALE: In addition to producing robust memory impairment, benzodiazepines also induce marked sedation. Thus, it is possible that the observed amnestic effects are secondary to more global sedative effects and do not reflect a specific primary benzodiazepine effect on memory mechanisms. OBJECTIVE: The objective was to use the nonspecific stimulant d-amphetamine to dissociate the sedative and memory-impairing effects of the benzodiazepine triazolam. MATERIALS AND METHODS: Single oral doses of placebo, triazolam alone (0.25, 0.50 mg/70 kg), d-amphetamine sulfate alone (20, 30 mg/70 kg), and triazolam (0.25, 0.50 mg/70 kg) and d-amphetamine sulfate (20, 30 mg/70 kg) conjointly (at all dose combinations) were administered to 18 healthy adult participants across nine sessions in a double-blind, staggered-dosing, crossover design. In addition to standard data analyses, analyses were also conducted on z-score standardized data, enabling effects to be directly compared across measures. RESULTS: Relative to the sedative measures, the memory measures generally exhibited a pattern of less reversal of triazolam's effects by d-amphetamine. The memory measures ranged in degree of reversal such that the most reversal was observed for reaction time on the n-back working memory task, and the least reversal was observed for accuracy on the Sternberg working memory task, with most measures showing an overall pattern of partial reversal. CONCLUSIONS: Benzodiazepines have specific effects on memory that are not merely a by-product of the drugs' sedative effects, and the degree to which sedative effects contribute to the amnestic effects varies as a function of the particular memory process being assessed.
Authors: O Blin; N Simon; E Jouve; M Habib; D Gayraud; A Durand; B Bruguerolle; P Pisano Journal: Clin Neuropharmacol Date: 2001 Mar-Apr Impact factor: 1.592
Authors: V S Mattay; J H Callicott; A Bertolino; I Heaton; J A Frank; R Coppola; K F Berman; T E Goldberg; D R Weinberger Journal: Neuroimage Date: 2000-09 Impact factor: 6.556
Authors: Olga Rass; Annie Umbricht; George E Bigelow; Eric C Strain; Matthew W Johnson; Miriam Z Mintzer Journal: Psychol Addict Behav Date: 2014-11-03
Authors: Lawrence P Carter; Bethea A Kleykamp; Roland R Griffiths; Miriam Z Mintzer Journal: Psychopharmacology (Berl) Date: 2012-10-25 Impact factor: 4.530
Authors: Olga Rass; Bethea A Kleykamp; Ryan G Vandrey; George E Bigelow; Jeannie-Marie Leoutsakos; Maxine L Stitzer; Eric C Strain; Marc L Copersino; Miriam Z Mintzer Journal: Exp Clin Psychopharmacol Date: 2014-02-17 Impact factor: 3.157
Authors: Marisa E Marraccini; Lisa L Weyandt; Joseph S Rossi; Bergljot Gyda Gudmundsdottir Journal: Exp Clin Psychopharmacol Date: 2016-08 Impact factor: 3.157
Authors: Olga Rass; Rebecca L Schacht; Katherine Buckheit; Matthew W Johnson; Eric C Strain; Miriam Z Mintzer Journal: Drug Alcohol Depend Date: 2015-08-24 Impact factor: 4.492